HLA Typing for Transplant Market Growth Analysis

HomeUncategorized

HLA Typing for Transplant Market Growth Analysis

HLA Typing for Transplant Market to Reach US$ 1189.6 mn by 2031, driven by the advances in transplantation technology: Global Insight Services New

Huawei Cheap H12-711_V4.0 Dumps & Exam H12-711_V4.0 Book – Latest H12-711_V4.0 Exam Forum
SPA and Pool Pump Market Trends [2022] | Growth Research Report
Everything You Need To Know About Implementing Python For Enterprise

HLA Typing for Transplant Market to Reach US$ 1189.6 mn by 2031, driven by the advances in transplantation technology: Global Insight Services

New York, November 2022: According to a new research study by Global Insight Services (GIS), the global HLA Typing for Transplant Market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 1189.6 million by 2031.

HLA typing is a laboratory test that is performed on a sample of a persons blood in order to determine their human leukocyte antigen (HLA) type. This information is used to match individuals with a compatible donor for bone marrow or stem cell transplants. HLA typing is performed using a technique called DNA sequencing. This involves taking a sample of blood and extracting the DNA. The DNA is then analyzed to identify the specific sequence of nucleotides (the building blocks of DNA) that make up the persons HLA type.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS24330/

HLA Typing for Transplant Market Market: Key Trends and Drivers

The demand for HLA Typing for Transplant is driven by the increasing number of transplant procedures being performed worldwide. The number of transplant procedures has increased due to the rising incidence of organ failure and the need for organ transplantation. The number of people suffering from organ failure is increasing due to the rising prevalence of chronic diseases such as diabetes and cardiovascular diseases. The number of people needing organ transplantation is also increasing due to the aging population.

The number of transplant procedures is also driven by the advances in transplantation technology. The advances in transplantation technology have made it possible to transplant organs from deceased donors. This has increased the number of organs available for transplantation. The advances in transplantation technology have also made it possible to transplant organs from living donors. This has increased the number of organs available for transplantation.

HLA Typing for Transplant Market Market: Restraints & Challenges

The key restraints and challenges in HLA typing for transplant market are the lack of awareness about the importance of HLA typing and the lack of trained personnel. HLA typing is a complex process and requires trained personnel to carry out the procedure.

There is a lack of awareness about the importance of HLA typing among the general population and this is a major challenge in the market. There is also a lack of trained personnel to carry out the procedure. This is a major challenge in the market as it requires skilled personnel to carry out the procedure.

HLA Typing for Transplant Market Report Findings

https://www.globalinsightservices.com/reports/hla-typing-for-transplant-market/

The molecular assay segment is likely to hold a dominant HLA Typing for Transplant Market share and grow at a substantial CAGR during the forecast period.

Based on the technology, the HLA typing for transplant market industry is bifurcated into g Non-molecular assays, and Molecular assays. Of these, the molecular assay segment registered revenue of around USD 2.72 billion in 2021. The molecular assays segment dominated the market share in 2021. Growing demand for molecular assays and increasing adoption rate along with advanced technologies that encourage customer buying behaviour are the major factors driving the industry expansion during the forecast timeframe. Also, associated advantages provided by molecular techniques are effective as compared to non-molecular assays that boost the demand for molecular assays segment growth.

The molecular assays are sub-classified into PCR based and sequencing based molecular assays. PCR technique is used for fast recognition of pathogens thus, became popular among the healthcare professionals and patients, thereby supplementing the industry revenue. Moreover, together with conventional PCR methods, the real-time PCR (RT-PCR) has developed as innovative technology and is increasingly being used in research laboratories and clinical diagnostics.

The reagents and consumables segment is anticipated to hold a majority of the HLA Typing for Transplant Market size throughout the study period.

By product and services, the industry is divided into Instruments, Reagents and consumables, Software, and Services. The Reagents and consumables segment of the HLA typing for transplant market is expected to grow at a rapid pace through 2031. The reagents and consumables segment in the HLA typing for transplant market exceeded highest market share in 2021. Reagents and consumables are used in large quantity and are frequently required for performing HLA typing. Thus, rising acceptance of reagents and consumables in transplant diagnostic technique is poised to impel the industry progression. Also, introduction of recent technologies causing development as well as enhancement of instruments stimulates the segment expansion in coming years. In addition, availability of diverse types of kits such as SBT kits (sequencing-based typing), SSO kits (sequence-specific oligonucleotides), SSP kits (sequence-specific primers) will stimulate the segment value.

The diagnostics segment is anticipated to hold a majority of the HLA Typing for Transplant Market size throughout the study period.

Based on applications, the HLA typing for transplant market industry is categorized diagnostics and research. The diagnostics segment accounted for lucrative market share in 2021. This is owing to the wide-ranging application in disease diagnosis coupled with availability of advanced and more specific gene testing techniques. Additionally, increasing implementation of HLA typing with PCR and other sequencing devices in healthcare administrations including diagnostics and advancements in research & development activities will accelerate the industry value. Moreover, the need for HLA matched bone marrow transplantation treatment for couples at risk with thalassaemic children is further slated to propel the industry size.

The diagnostic labs segment is anticipated to hold a majority of the HLA Typing for Transplant Market size throughout the study period.

Based on the end-user, the industry is categorized into hospitals, diagnostic labs, academic and research institutes. Among these, the diagnostic labs segment is expected to depict significant CAGR from 2022 to 2031. This is impelled by the increasing number of HLA testing due to high demand for transplant procedures. For instance, according to the Global Observatory on Donation & Transplantation, nearly 157,301.0 organ transplantation were performed in 2019. The report also stated that, around 150,407.0 organ transplantation were performed in 2018.

The Asia-Pacific region is estimated to exhibit the highest growth rate during the HLA Typing for Transplant Market forecast period.

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. Asia-Pacific region holds a significant market due to the improved infrastructure of the healthcare facilities, better healthcare reimbursement policies, and better economic growth which positively boosts the market. Along with this skilled professionals and availability of the transplant hospitals, and laboratories with advanced technologies will boost the market.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS24330/

Competitive Landscape

The global HLA Typing for Transplant Market report includes players such as Abbott, Bio-Rad Laboratories, CareDx, Qiagen N.V., Thermo Fischer Scientific, F. Hoffmann-La Roche Ltd, Illumina Inc., Luminex Corporation and Immucor, Inc, Hologic, Inc., Luminex, and Biofortuna, among others.

 

.Recent Developments in the HLA Typing for Transplant Market:

  • In September 2022, Qiagen announced new additions to its NeuMoDx assay menu for organ transplant-associated viruses.
  • In July 2022, Qiagen expanded PCR portfolio, launches custom assay service
  • In August 2021, QIAGEN and GT Molecular collaborated to offer a complete SARS-CoV-2 wastewater detection solution based on QIAcuity Digital PCR technology
  • In April 2021, CareDx announced that they have launched a fully-functional next generation sequencing (NGS) HLA typing service lab in Stockholm, Sweden to support companies in research and academic studies working on HLA applications in vaccine and drug development as well as disease association studies.

HLA Typing for Transplant Market Report Coverage

  • The report offers a comprehensive quantitative as well as qualitative analysis of the current global HLA Typing for Transplant Market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
  • A thorough analysis of market trends and restraints is provided.
  • Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
  • The forecasts in this report are made by examining the recent trends along with future HLA Typing for Transplant Market potential from 2021 to 2031 in terms of revenue.
  • Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the HLA Typing for Transplant Market are also analyzed.
  • Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global surface disinfectants industry.

Global HLA Typing for Transplant Market Segmentation

By Technology

  • Non-molecular assays
  • Molecular assays

By Product & Services

  • Instruments
  • Reagents and consumables
  • Software
  • Services

By Application

  • Diagnostics
  • Research

By End-use

  • Hospitals
  • Diagnostic labs
  • Academic and research institutes

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Rest of World
    • Latin America
    • Middle East
    • Africa

Key Players

  • Abbott
  • Bio-Rad Laboratories
  • CareDx
  • Qiagen N.V.
  • Thermo Fischer Scientific
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc
  • Luminex Corporation
  • Immucor, Inc
  • Hologic, Inc.
  • Luminex
  • Biofortuna

COMMENTS